View More Recent Stories

Apr 29, 2021 04:49PM NANOBIOTIX Announces First Quarter Operational and Financial Updates
Apr 28, 2021 04:15PM NANOBIOTIX to Present Four Posters Including Updates From Priority Head and Neck Cancer and Immunotherapy Development Pathways at the 2021 Annual Meeting of the American Society for Clinical Oncology
Apr 12, 2021 12:00PM Nanobiotix Combined Shareholders Meeting to Be Held April 28, 2021
Apr 7, 2021 06:27PM NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F
Mar 17, 2021 05:15PM NANOBIOTIX Reports Full Year 2020 Financial Results and Highlights Operational Progress
View More Recent Stories